Summary of Significant Accounting Policies (Details) - USD ($) |
2 Months Ended | 3 Months Ended | |
|---|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2021 |
Dec. 31, 2020 |
|
| Accounting Policies [Abstract] | |||
| Underwriters discount paid | $ 9,986,000 | ||
| Discount paid on deferred offering costs | 9,488,000 | ||
| Deferred cost charged to equity | 9,596,000 | ||
| Other expense for warrant liability | $ 390,000 | ||
| Public share sold (in Shares) | 17,250,000 | ||
| Net tangible assets | $ 5,000,001 | ||
| Share of common stock (in Shares) | 13,669,161 | 14,077,350 | |
| Share of classified permanent equity (in Shares) | 17,250,000 | ||
| Subject to forfeiture of shares (in Shares) | 14,325,000 | ||
| Federal depository insurance coverage | $ 250,000 | ||
| Income tax expense | $ 0 | $ 0 | |
| Effective tax rate percentage | 0.00% | 0.00% | |
| Deferred tax assets | $ 550,000 | $ 200,000 |
| X | ||||||||||
- Definition Federal depository insurance coverage. No definition available.
|
| X | ||||||||||
- Definition Public share sold No definition available.
|
| X | ||||||||||
- Definition Share of classified permanent equity. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized. No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of issuance costs recognized in a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, after deduction of accumulated amortization or the effects of subsequent adjustments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares (or other type of equity) forfeited during the period. No definition available.
|